Literature DB >> 32251735

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA.

Marta Arévalo1, Clementina López-Medina2, Mireia Moreno Martinez-Losa1, Anna Moltó2, Pilar Font3, Eduardo Collantes-Estevez3, Jordi Gratacós4.   

Abstract

OBJECTIVE: To analyze the potential association between the presence of HLA-B27 and the different comorbidities observed in Axial Spondyloarthritis patients.
METHODS: A comparative cross-sectional study including Axial Spondyloarthritis patients from COMOSPA registry. COMOSPA is a worldwide registry that includes a wide set of anthropometric and clinical variables from 3984 patients with Spondyloarthritis. The registry also includes the most frequent comorbidities observed in Spondyloarthitis such as obesity, hypertension, diabetes, hyperlipidemia, heart ischemic disease, stroke, renal failure, neoplasms, peptic ulcer, diverticulitis, chronic obstructive pulmonary disease, and the presence of osteoporosis. A descriptive analysis and a multiple logistic regression model was performed including all variables assessed.
RESULTS: 2370 patients fulfilled ASAS criteria of Axial Spondyloarthritis patients and were included in the study. 1858 (78.4%) of them were HLA-B27 positive. HLA-B27 positive Axial Spondyloarthritis patients presented significantly higher percentage of male sex, longer disease duration, higher percentage of definite Ankylosing Spondylitis, higher CRP levels, and were also more frequent tobacco consumers and excessive alcohol intakers compared to the negatives. However, disease activity measured by BASDAI, BASFI and ASDAS-CRP were all significantly higher in the HLA-B27 negative patients compared to the positive ones. The only association observed between any comorbidity and presence of HLA-B27 genotype was the presence of osteoporosis, even after adjusting in the multivariate analysis for all variables assessed.
CONCLUSION: The association observed between the HLA-B27 genotype and the presence of osteoporosis in Axial Spondyloarthritis patients could be of great relevance given the impact of osteoporosis in the phenotypical frame of these patients.
Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ankylosing Spondylitis; Cardiovascular disease; Comorbidities; HLA-B27; Osteoporosis; Spondyloarthritis

Mesh:

Substances:

Year:  2020        PMID: 32251735     DOI: 10.1016/j.jbspin.2020.03.012

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  6 in total

1.  Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.

Authors:  Hatice Bodur; Fatma Gul Yurdakul; Sebnem Ataman; Hasan Fatih Cay; Gulcan Gurer; Erhan Capkin; İlhan Sezer; Mehmet Tuncay Duruoz; Meltem Alkan Melikoglu; Aylin Rezvani; Ilker Yagci; Feride Gogus; Ayhan Kamanli; Ozgur Akgul; Remzi Cevik
Journal:  Clin Rheumatol       Date:  2022-03-30       Impact factor: 2.980

Review 2.  Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease.

Authors:  Pradnya Brijmohan Bhattad; Mugdha Kulkarni; Parasbhai D Patel; Mazen Roumia
Journal:  Cureus       Date:  2022-06-03

3.  Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool.

Authors:  Ji-Won Kim; Sunghoon Park; Ju-Yang Jung; Hyoun-Ah Kim; Seong-Ryul Kwon; Sang Tae Choi; Sung-Soo Kim; Sang-Hyeon Kim; Chang-Hee Suh
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

4.  Empirical Study of Large-Scale HLA Simulation of Parallel Region-Matching Knowledge Recognition Algorithm Based on Region Matching.

Authors:  Guohua Zhu; Haizhou Wang
Journal:  Comput Intell Neurosci       Date:  2022-04-11

5.  Comparison of immune cells and diagnostic markers between spondyloarthritis and rheumatoid arthritis by bioinformatics analysis.

Authors:  Jiaqian Wang; Yuan Xue; Liang Zhou
Journal:  J Transl Med       Date:  2022-05-04       Impact factor: 8.440

6.  Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis.

Authors:  Sara Remuzgo-Martínez; Javier Rueda-Gotor; Verónica Pulito-Cueto; Raquel López-Mejías; Alfonso Corrales; Leticia Lera-Gómez; Raquel Pérez-Fernández; Virginia Portilla; Íñigo González-Mazón; Ricardo Blanco; Rosa Expósito; Cristina Mata; Javier Llorca; Vanesa Hernández-Hernández; Carlos Rodríguez-Lozano; Nuria Barbarroja; Rafaela Ortega-Castro; Esther Vicente; Cristina Fernández-Carballido; María Paz Martínez-Vidal; David Castro-Corredor; Joaquín Anino-Fernández; Diana Peiteado; Chamaida Plasencia-Rodríguez; Eva Galíndez-Agirregoikoa; María Luz García-Vivar; Nuria Vegas-Revenga; Irati Urionaguena; Oreste Gualillo; Juan Carlos Quevedo-Abeledo; Santos Castañeda; Iván Ferraz-Amaro; Miguel Á González-Gay; Fernanda Genre
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.